Contact
![Contact Meredith Alda](https://cdn.statcdn.com/contactPerson/3646.jpg)
Mon - Fri, 9am - 6pm (EST)
![Contact Yolanda Mega](https://cdn.statcdn.com/contactPerson/3195.jpg)
Mon - Fri, 9am - 5pm (SGT)
![Contact Kisara Mizuno](https://cdn.statcdn.com/contactPerson/2661.jpg)
Mon - Fri, 10:00am - 6:00pm (JST)
![Contact Lodovica Biagi](https://cdn.statcdn.com/contactPerson/863.jpg)
Mon - Fri, 9:30am - 5pm (GMT)
![Contact Carolina Dulin](https://cdn.statcdn.com/contactPerson/3012.jpg)
Mon - Fri, 9am - 6pm (EST)
Key regions: Germany, Italy, France, Japan, United Kingdom
The Ophthalmic Devices market in CIS is experiencing significant growth and development due to various factors. Customer preferences for advanced and innovative ophthalmic devices, along with the increasing prevalence of eye disorders, are driving the market growth in the region. Additionally, local special circumstances and underlying macroeconomic factors are also contributing to the expansion of the market. Customer preferences in the CIS region are shifting towards technologically advanced ophthalmic devices. Patients are increasingly seeking devices that offer better accuracy, precision, and comfort during eye examinations and surgeries. This has led to the demand for devices such as optical coherence tomography (OCT) machines, phacoemulsification systems, and advanced diagnostic tools. The preference for these devices is driven by the desire for improved treatment outcomes and enhanced patient experience. The market in the CIS region is also driven by the increasing prevalence of eye disorders. Factors such as aging population, changing lifestyles, and environmental factors contribute to the rising incidence of eye diseases such as cataract, glaucoma, and refractive errors. As a result, there is a growing need for ophthalmic devices for diagnosis, treatment, and management of these conditions. The demand for devices such as intraocular lenses, ophthalmic lasers, and refractive surgery devices is increasing to cater to the growing patient population. In addition to customer preferences, there are local special circumstances that contribute to the development of the Ophthalmic Devices market in the CIS region. The region has a relatively high prevalence of certain eye disorders compared to other parts of the world. This necessitates the availability of advanced ophthalmic devices for effective diagnosis and treatment. Furthermore, the healthcare infrastructure in the region is continuously improving, leading to increased accessibility and affordability of ophthalmic devices for both patients and healthcare providers. Underlying macroeconomic factors also play a role in the growth of the Ophthalmic Devices market in the CIS region. The region has witnessed economic growth in recent years, leading to increased healthcare spending. This allows healthcare providers to invest in advanced ophthalmic devices and technologies. Additionally, favorable government policies and initiatives to improve healthcare infrastructure and services further support the market growth. In conclusion, the Ophthalmic Devices market in the CIS region is developing due to customer preferences for advanced devices, the increasing prevalence of eye disorders, local special circumstances, and underlying macroeconomic factors. The demand for technologically advanced devices and the need for effective diagnosis and treatment of eye disorders are driving the market growth. With the continuous improvement in healthcare infrastructure and favorable economic conditions, the market is expected to further expand in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)